This is a preview of subscription content, log in via an institution to check access.
Notes
using a blood test for HCV antibodies
simeprevir+PEG IFN+RBV (genotype 1), sofosbuvir+RBV (genotype 2/3) or PEG IFN+RBV (genotypes 4/5/6)
Reference
Wong WW, et al. Cost-effectiveness of screening for hepatitis C in Canada. CMAJ: Canadian Medical Association Journal : 12 Jan 2015
Rights and permissions
About this article
Cite this article
Cost effectiveness of HCV screening in Canada. PharmacoEcon Outcomes News 720, 15 (2015). https://doi.org/10.1007/s40274-015-1854-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-1854-y